STOCKSCREENR

0N4A.L

LSE

Vivesto AB

$0.08+0.00(+0.97%)Mkt Cap: $43.74M

Key Stats

Market Cap

$43.74M

P/E Ratio

-0.32

EPS

$-0.26

Dividend Yield

0.00%

52-Week Range

$0.08 — $0.49

Volume

4.48M

Avg Volume

2.03K

Beta

0.97

Price Alerts for 0N4A.L

Get alerted when 0N4A.L hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

-0.32

Forward P/E

—

PEG Ratio

-0.18

P/S (TTM)

0.00

P/B (TTM)

0.39

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-0.25%

ROA (TTM)

-0.23%

ROIC

—

Gross Margin

0.00%

Operating Margin

0.00%

Net Margin

—

Debt/Equity

0.10

Current Ratio

0.22

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

-0.01%

EPS Growth (5Y)

-0.00%

Sales Growth (3Y)

-0.24%

Sales Growth (5Y)

+11.63%

EPS Est (This Year)

$-0.03

EPS Est (Next Year)

$-0.03

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$0.00

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

487.33M

Float

487.23M

Free Float %

99.98%

About

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Country

SE

Exchange

LSE

IPO Date

2005-01-01

Employees

4

CEO

Erik Kinnman Assoc.

Index Membership

—

Website

https://www.vivesto.com

Vivesto AB (0N4A.L) is a healthcare company in the medical - pharmaceuticals industry listed on the LSE. With a market capitalization of $43.74M, a P/E ratio of -0.32, 0N4A.L is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare 0N4A.L against other stocks using dozens of fundamental and technical filters.

Similar Stocks

SDEV

Stablecoin Development Corp.

$1.24

-2.36%

$33.02M

0DOL.L

Biofrontera AG

$2.50

+1.63%

$111.43M

MSLE

Satellos Bioscience Inc. Common Stock

$7.95

+9.35%

$10.24M

KYNB

Kyntra Bio, Inc.

$7.27

+3.12%

$29.42M

0IL8.L

Kyntra Bio, Inc.

$7.23

+2.40%

$29.21M

0GP7.L

Medivir AB (publ)

$1.84

-7.35%

$210.19M

Frequently Asked Questions

What is Vivesto AB's P/E ratio?

Vivesto AB (0N4A.L) has a trailing twelve-month (TTM) P/E ratio of -0.32. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Vivesto AB pay a dividend?

No, Vivesto AB (0N4A.L) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Vivesto AB's market cap?

Vivesto AB (0N4A.L) has a market capitalization of $43.74 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.